Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.
about
Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patientsFriend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphomaThe Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseSequential monitoring of lymphocyte subsets and of T-and-B cell neogenesis indexes to identify time-varying immunologic profiles in relation to graft-versus-host disease and relapse after allogeneic stem cell transplantationAn activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers.The biology of graft-versus-host disease: experimental systems instructing clinical practice.Current issues in chronic graft-versus-host disease.Anti-thymocyte globulin (ATG) differentially depletes naïve and memory T cells and permits memory-type regulatory T cells in nonobese diabetic mice.Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.Thymic T-cell development in allogeneic stem cell transplantationBiomarkers in chronic graft-versus-host diseaseInhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantationImmune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome.Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation.National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.Regulatory T cells for tolerance therapy: revisiting the concept.A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease.Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation.Topical application of FTY720 and cyclosporin A prolong corneal graft survival in mice.CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations.Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation.Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host diseaseThe development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway.B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathwaysRabbit antithymocyte globulin (thymoglobulin) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients.Interleukin-10 spot-forming cells as a novel biomarker of chronic graft-versus-host disease.Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD.Suppression of IL-7-dependent Effector T-cell Expansion by Multipotent Adult Progenitor Cells and PGE2.Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism.Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplantLongitudinal evaluation of regulatory T-cell dynamics on HIV-infected individuals during the first 2 years of therapyAntibodies are back for thymic attack in cGVHD.Approaches for the prevention of graft-versus-host disease following hematopoietic cell transplantationCirculating T follicular helper cells with increased function during chronic graft-versus-host diseaseLow-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease.Interleukin-2 and regulatory T cells in graft-versus-host disease.Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease.
P2860
Q26787230-D579ECCA-8ECF-42BE-9502-AEC85938CE6CQ28072320-6653A93A-DF28-46FA-896E-0F426830E496Q28076264-74B70152-C06C-462C-B9A6-65CF3FFFE7D1Q33554385-F2118884-EBED-4F9A-9AB3-F6FBD14F3C9AQ33798102-889DAB20-5BE4-4C97-9C9A-4EE42A065B18Q33870728-32754697-3347-48A4-AE09-8D3C2674501BQ33917175-1E8A3396-252B-40DC-8894-93FD93FC0DA8Q33917187-53B03F79-778B-4774-BF00-31358A65E0DFQ34511576-FE200B17-DE28-4BDC-A5C1-A0F3DCC531A0Q34707354-C1E873F3-9EAE-4F7C-82DB-F651A9AAE613Q35022269-2D4F164D-E8CB-4156-B287-E69686727C85Q35083246-79A62925-F90F-4367-9B2C-DEC1026B7875Q35094374-06E740EB-2E78-46D2-99B0-D51578C407C6Q35128301-F561C262-530E-479A-B5E1-34BCE2748B23Q35230703-04141533-E926-4B8F-BD01-AEA758BA404FQ35525729-D5584ED8-3435-46A8-9EAF-AA3B91E195FCQ35533376-8B7999AC-100B-4CEB-9A8A-D2F20FCCEF2FQ35621984-A662F5D5-8A3E-47B0-9F13-1EFE4BC84F04Q35737769-FE4BF214-16ED-4F24-9EAE-C8C24F0BAD3EQ35784548-CB170971-5920-4FAF-A1C3-71C5F101694CQ35883316-FAAE0B5E-EE4A-4DAB-8FCF-E870174F7D3BQ35888837-6D30BDA9-35A0-4655-8B99-362B2C0D2032Q36036340-2AD8CCA6-07E1-466B-B0CB-2043CEE60DF3Q36040293-FC084AE3-C8CA-4889-800F-E331D7968315Q36058558-772D961C-E972-4CB3-B81E-2A6195BB4024Q36075960-82256195-7E9D-44AC-B1E1-A59E38A188F2Q36250962-C60874FC-C93F-4E1A-98F4-E16E126A5EF3Q36498340-E1E219BB-83AB-40FC-A2D2-18B0DD49CB15Q36498345-5B15AD0C-84A9-46F1-B828-BBF9984295ABQ36547819-52742425-2E61-42A9-9882-C795A06FB5EEQ36757169-7AC8552D-59A3-4ADD-8D90-DD045B5E6780Q36851405-12922B47-9165-4901-88E3-9015C59992C4Q36862415-8CFFCC11-A644-4E34-AA70-922B002729D8Q36868157-449CA790-AB0D-4C6A-8958-98ACBA780EF8Q36876960-D5763C5E-62FA-4EA0-A5EC-238FF748901BQ36891433-00F47DD0-BFBC-4DBE-8A04-E614BD695EA5Q36920466-157788AD-4B15-423B-8236-C1C0B68E14B9Q36940174-2B29395B-E57D-4FFC-A73A-DBCB0E1A8009Q37055805-3BF609F8-0330-4805-BAFF-A3AE35633B27Q37064425-7090F81A-56E9-445A-B58D-EEBDA4FF9517
P2860
Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Altered regulatory T cell home ...... tic stem cell transplantation.
@ast
Altered regulatory T cell home ...... tic stem cell transplantation.
@en
type
label
Altered regulatory T cell home ...... tic stem cell transplantation.
@ast
Altered regulatory T cell home ...... tic stem cell transplantation.
@en
prefLabel
Altered regulatory T cell home ...... tic stem cell transplantation.
@ast
Altered regulatory T cell home ...... tic stem cell transplantation.
@en
P2093
P2860
P356
P1476
Altered regulatory T cell home ...... etic stem cell transplantation
@en
P2093
Ben Warshauer
Corey Cutler
Edwin P Alyea
Gregory Bascug
Haesook T Kim
John Koreth
Joseph H Antin
Ken-ichi Matsuoka
Robert J Soiffer
Sean McDonough
P2860
P304
P356
10.1172/JCI41072
P407
P50
P577
2010-04-12T00:00:00Z